BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33360370)

  • 1. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway.
    Tang J; Xu L; Zeng Y; Gong F
    Int Immunopharmacol; 2021 Feb; 91():107272. PubMed ID: 33360370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
    Li R; Yang H; Xue Y; Xianqin L
    J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
    Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
    Front Immunol; 2021; 12():679897. PubMed ID: 34367139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive Effect of the Total Polyphenols from
    Li C; Qi X; Xu L; Sun Y; Chen Y; Yao Y; Zhao J
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice : Gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway.
    Sun Y; Yan T; Gong G; Li Y; Zhang J; Wu B; Bi K; Jia Y
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107029. PubMed ID: 33045567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain Axis.
    Nie H; Ge J; Yang K; Peng Z; Wu H; Yang T; Mei Z
    Drug Des Devel Ther; 2023; 17():3571-3588. PubMed ID: 38058793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
    Liu D; Guo R; Shi B; Chen M; Weng S; Weng J
    Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of
    Shi K; Xiao Y; Dong Y; Wang D; Xie Y; Tu J; Xu K; Zhou Z; Cao G; Liu Y
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
    Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
    Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP18 mitigates lipopolysaccharide-induced oxidative stress and inflammation in human pulmonary microvascular endothelial cells through the TLR4/NF-κB/ROS signaling.
    Jiang Z; Shen J; Ding J; Yuan Y; Gao L; Yang Z; Zhao X
    Toxicol In Vitro; 2021 Sep; 75():105181. PubMed ID: 33930521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-
    Tang Y; Ding F; Wu C; Liu B
    Anal Cell Pathol (Amst); 2021; 2021():6653681. PubMed ID: 34426780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
    Wu X; Lin L; Wu H
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
    Kong D; Wang Z; Tian J; Liu T; Zhou H
    J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
    Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.